Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Certara, Inc. - Common Stock
(NQ:
CERT
)
12.82
-0.17 (-1.31%)
Streaming Delayed Price
Updated: 11:20 AM EST, Jan 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Certara, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Expert Ratings for Certara
March 27, 2023
Via
Benzinga
Are These 3 Small Momentum Stocks Setting Up Big Gains?
March 22, 2023
MINISO, PDF Solutions, and Certara are small stocks with strong price momentum. It’s not unusual for small stocks to show more price momentum than larger peers.
Via
MarketBeat
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
Where Certara Stands With Analysts
March 02, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
March 16, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
A.I. Coming to Certara’s D360 Scientific Informatics Software
March 09, 2023
New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses.
From
Certara
Via
GlobeNewswire
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
March 07, 2023
Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies
From
Certara
Via
GlobeNewswire
Macy's, Big Lots, Sprouts Farmers Market And Other Big Stocks Moving Higher On Thursday
March 02, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
March 01, 2023
Annual Revenue Grows 17% on a Reported Basis and 20% at Constant Currency
From
Certara
Via
GlobeNewswire
Certara Announces Transition Plan for Chief Financial Officer
March 01, 2023
From
Certara
Via
GlobeNewswire
Certara to Participate in the Barclays Global Healthcare Conference
February 27, 2023
From
Certara
Via
GlobeNewswire
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
February 01, 2023
From
Certara
Via
GlobeNewswire
Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
January 04, 2023
Certara improves software capabilities by expanding into deep learning and data fabric
From
Certara
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
December 08, 2022
Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity
From
Certara
Via
GlobeNewswire
Why Certara's Shares Rose 37.7% This Week
November 11, 2022
The company, which helps other companies in their drug development, reported strong third-quarter numbers.
Via
The Motley Fool
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
November 08, 2022
U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Gainers
Via
Benzinga
Certara Reports Third Quarter 2022 Financial Results
November 07, 2022
Biosimulation software and services fuel third quarter growth
From
Certara
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
November 07, 2022
Gainers
Via
Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
November 07, 2022
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Via
Benzinga
Dow Up Triple Digits Ahead Of Busy Week
November 07, 2022
The Dow Jones Industrial Average is up 212 points midday, continuing Friday's flourish, while the Nasdaq Composite and S&P 500 Index sit more hesitantly in the black.
Via
Talk Markets
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
November 07, 2022
Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares
From
Certara
Via
GlobeNewswire
Earnings Outlook For Certara
November 04, 2022
Certara (NASDAQ:CERT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Certara will report...
Via
Benzinga
Certara to Participate in Upcoming Investor Conferences
November 02, 2022
From
Certara
Via
GlobeNewswire
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
October 19, 2022
The PMDA enters 9th consecutive year of using Certara’s software
From
Certara
Via
GlobeNewswire
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
October 13, 2022
From
Certara
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.